As Congressional lawmakers push to negotiate prices for Medicare Part D, a new analysis finds the federal government could have saved $14.4 billion on the top 50 pills that were covered two years ago if the program obtained the same prices as the Department of Veterans Affairs, which already haggles for discounts.

For instance, the Part D plan spent $3 billion on the Harvoni hepatitis C treatment sold by Gilead Sciences (GILD) in 2016 – more on this particular pill that year than any other oral medicine – but could have spent $1.7 billion if using VA pricing. Similarly, the program spent $1.8 billion on the Revlimid cancer treatment sold by Celgene  (CELG), but could have spent $1.2 billion with VA prices.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Medicare have the nerve to put on my prescription form that when I pay $47 for my insulin they saved me over $900, I can get in Mexico for $120 which I have to do due to donut hole being achieved very quickly at those ridiculous prices. Clinton negotiated with the pharmaceutical companies that would not let Medicare negotiate with them. This needs to change or we should buy exactly same medications from Mexico and bypass the greedy big business in the U.S

  • If Medicare part D was watching the PBM’s they would have saved 30 Billion
    in 2016. There has to be total transparency dealing with the PBM’s ! That is the ONLY way the government will save money. After all they have no laws governing them. So they really do whatever they want to do. And there are no laws to stop them ! PBM’s want everything to stay the same. If they do stay the same, I can assure you, there will not be one Independent pharmacy left in this country.

  • And why doesn’t Part D negotiate prices? If memory serves NOT doing that was because Big Pharma came to the table for the ACA and negotiated that. (Just sayin’ …. )

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy